FDA Targets GLP 1 and Peptide Compounding, Advertising and 'Research Use Only' Labeling FDA to weigh easing limits on unproven peptides favored by RFK Jr. and MAHA supporters PBS News On August 15 2025, the U.S. Food & Drug Administration (FDA) issued a Warning Letter to Platinum Biologics LLC for marketing umbilicalcordderived products including exosome products (NanoEx & Nano Xsomes) without approval. The FDA will hold a meeting to consider easing restrictions on more than a half dozen peptide injections, a group of unapproved therapies that have become popular among wellness influencers, fitness gurus Is BPC 157 Banned? Oral vs. Injectable Forms Explained The U.S. Food and Drug Administration is moving toward allowing compounding pharmacies to produce more than a dozen injectable peptides that were banned because of potentially significant safety risks, the New York